ArticleScience advances2024

ACSL6-activated IL-18R1-NF-κB promotes IL-18-mediated tumor immune evasion and tumor progression.

Yuqin Di et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.